| Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. | |
| | |
MedLine Citation:
|
PMID: 21328634 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: To describe the characteristics of patient reporters to the UK's Yellow Card Scheme (YCS) and the suspect drugs reported, and to determine patient views and experiences of making a Yellow Card report. METHODS: A questionnaire was developed for distribution by the Medicines and Healthcare products Regulatory Agency (MHRA) to all patients reporting through the YCS between March 2008 and January 2009. Associations between reporting method (online, postal and telephone) and questionnaire responses were examined using Pearson's Chi-squared test. RESULTS: Evaluable questionnaires were returned by 1362 out of 2008 reporters (68%). Respondents' median (IQR) age was 56.5 (43.0, 67.0) years, 910 (66.8%) were female, 1274 (93.5%) were white and 923 (67.8%) had at least a further education qualification. The most frequent reporting method was postal (59.8%), followed by online (32.8%) and telephone (6.3%). Online reporters were younger with a higher education level than those using other reporting methods. Most respondents, 1274 (93.6%), thought that the report was fairly or very easy to complete, although many identified the need for improvements to the system. One third (n = 448; 32.9%) expected feedback from the MHRA and 828 (60.8%) would have liked feedback. Almost all respondents (n = 1302; 95.6%) would report again. CONCLUSIONS: The majority of patients found the current methods of reporting suspected ADRs easy to use and would recommend them to others. Different methods of reporting were used by different demographic subgroups of reporters. Improvements to the system, including the provision of feedback to reporters, could be made. Copyright © 2011 John Wiley & Sons, Ltd. |
| | |
Authors:
|
David J McLernon; Christine M Bond; Amanda J Lee; Margaret C Watson; Philip C Hannaford; Heather Fortnum; Janet Krska; Claire Anderson; Elizabeth Murphy; Anthony Avery; |
Related Documents
:
|
22397944 - Effectiveness of the lucas device for mechanical chest compression after cardiac arrest... 21445814 - Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis. 3392274 - Histoplasmosis involving the omentum in an aids patient: ct demonstration. 14752964 - Bone graft augmentation and dental implant treatment in a patient with osteogenesis imp... 16410154 - Nuclear forensic investigations: two case studies. 15185074 - Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ur... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-17 |
Journal Detail:
|
Title: Pharmacoepidemiology and drug safety Volume: - ISSN: 1099-1557 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9208369 Medline TA: Pharmacoepidemiol Drug Saf Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 John Wiley & Sons, Ltd. |
Affiliation:
|
University of Aberdeen, Aberdeen, UK. d.mclernon@abdn.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Safety of non-therapeutic levetiracetam ingestions-a poison center based study.
Next Document: Mediating role of peritraumatic dissociation and depression on post-MVA distress: path analysis.